Portfolio company
TriRx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
TriRx manufactures pharmaceuticals and biopharmaceuticals, including monoclonal antibodies, for global human and animal health companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
mAbxience
This company develops and manufactures biosimilar monoclonal antibodies and provides contract development and manufacturing services to partners in the global biopharmaceutical industry.
Boehringer Ingelheim
This company develops and manufactures pharmaceutical products for human healthcare and animal welfare across global markets.
trioar
This biotechnology firm develops antibody-based therapeutic platforms and drug conjugates for pharmaceutical companies and research partners to treat cancer.
CordenPharma
This company manufactures active pharmaceutical ingredients and drug products for pharmaceutical and biotechnology businesses.
Talix
This drug development company creates monoclonal antibodies for healthcare providers and pharmaceutical partners to treat various forms of cancer through immune-based therapies.
Cambrex
This company develops and manufactures active pharmaceutical ingredients and drug products for global pharmaceutical and biotechnology customers.
Arxx Therapeutics
This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.